Cytomegalovirus Therapy
Leflunomide is possible alternative for gangciclovir sensitive and resistant CMV infection
Published in Cancer Weekly, July 4th, 2006
"The search for newer more cost effective treatments for infectious diseases remains a challenge. Cytomegalovirus (CMV) infection, which is especially common in the immunosuppressed, is an important challenge for treating physicians," researchers in India report.
According to the authors, "Gangciclovir's cost is a major hurdle in developing countries. Leflunomide is cheaper and is easily given orally. It works by a novel mechanism inhibiting virion assembly.
"It also has immunosuppressive properties," and has "been shown to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-07-04)
More Articles from Cancer Weekly
- Cancer Therapy
Anticancer and antimetastatic properties of doenjang increased with longer aging time - Cancer Therapy
Tumor necrosis factor alpha blockade suggested as adjunct to cancer therapies - Chemotherapy Side Effects
Etoposide-induced alopecia suppressed by MMK-1 bound to FPRL1 receptor - Male Breast Cancer
Male breast cancer detected by comparative genomic hybridization analysis - Mesothelioma
Pleural malignant mesothelioma, epithelioid type, diagnosed by h-caldesmon - Acoustic Neuroma
Acoustic neuroma conservative management requires further studies - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
